---

---

entities : Glaxosmithkline plc   

save search

---

Rheumatoid Arthritis Drugs Market to grow by USD 16.04 billion from 2023 to 2028; North America to account for 39% of market growth- Technavio
Published: 2023-12-04 (Crawled : 18:00) - prnewswire.com
ALPMF | $9.17 -4.42% 43.47% 16K |

Health Technology

| -18.56% | O: 0.26% H: 0.0% C: 0.0%
GLAXF | $20.2 0.65% -14.18% 0 |

Health Technology

| 9.78% | O: -2.6% H: 1.1% C: -1.18%
SNYNF | News | $92.7 -2.18% 600K |

Health Technology

| -1.28% | O: 0.27% H: 0.12% C: 0.12%
NVSEF | $93.6375 6.88% 82K |

Health Technology

| -4.4% | O: -1.1% H: 0.0% C: 0.0%
ALPMY | $9.47 0.11% -1.11% 10K |

Manufacturing

| -22.81% | O: 0.0% H: 0.5% C: 0.17%
NVS | $92.57 -0.55% 0.51% 0 |

Health Technology

| -5.97% | O: -1.86% H: 0.34% C: -0.19%
GSK | $39.27 -0.83% 0.38% 3.8K |

Health Technology

| 8.11% | O: -1.01% H: 0.39% C: 0.19%
ABBV | News | $164.66 0.25% -0.55% 0 |

Health Technology

| 15.19% | O: 0.51% H: 0.68% C: 0.32%
SNY | News | $45.39 -1.56% -1.58% 4.3M |

Health Technology

| -2.73% | O: -0.5% H: 0.0% C: 0.0%
GLMD | $0.3787 2.8% -0.41% 2.2K |

Health Technology

| -5.1% | O: 0.03% H: 2.44% C: -1.03%
AMGN | $262.75 -0.5% -0.49% 320 |

Health Technology

| -2.79% | O: -0.25% H: 0.05% C: -0.37%
america market

---

Geron Corporation Announces Appointment of Gaurav Aggarwal, M.D., to its Board of Directors
Published: 2023-11-28 (Crawled : 21:00) - biospace.com/
UNCY | $1.09 -5.63% -5.96% 1.7K |

Professional, Scientific, and T...

| 94.09% | O: -6.96% H: 7.9% C: 3.35%
GSK | $39.27 -0.83% 0.38% 3.8K |

Health Technology

| 11.14% | O: -0.51% H: 0.96% C: 0.54%
GERN | $3.73 1.36% 1.08% 2K |

Health Technology

| 92.67% | O: -1.05% H: 2.65% C: 1.06%
corporation

---

Gonorrhea Therapeutics Market to grow by USD 506.68 million from 2022 to 2027; North America accounts for 39% of market growth - Technavio
Published: 2023-11-21 (Crawled : 20:00) - prnewswire.com
GLAXF | $20.2 0.65% -14.18% 0 |

Health Technology

| 12.47% | O: -3.23% H: 0.0% C: -0.35%
GSK | $39.27 -0.83% 0.38% 3.8K |

Health Technology

| 11.93% | O: -0.23% H: 0.2% C: -0.28%
america therapeutics growth market

---

Ewing's Sarcoma Treatment Market to grow by USD 205.09 million from 2024-2028; North America to account for 48% of market growth - Technavio
Published: 2023-11-20 (Crawled : 19:00) - prnewswire.com
NVS | $92.57 -0.55% 0.51% 0 |

Health Technology

| -2.28% | O: 0.91% H: 0.6% C: 0.27%
GSK | $39.27 -0.83% 0.38% 3.8K |

Health Technology

| 12.79% | O: 0.51% H: 0.77% C: 0.26%
BAX | $39.65 0.33% 0.0% 5 |

Health Technology

| 11.45% | O: 0.39% H: 0.2% C: -0.17%
america treatment growth market

---

Unraveling the Shifting Rare Eye Diseases Market Landscape: Analysis of Retinoblastoma Market, Retinitis Pigmentosa Market, Limbal Stem Cell Deficiency Market, Leber Hereditary Optic Neuropathy Market, and Stargardt Disease Market | DelveInsight
Published: 2023-11-16 (Crawled : 22:00) - prnewswire.com
GLAXF | $20.2 0.65% -14.18% 0 |

Health Technology

| 17.78% | O: -2.04% H: 0.0% C: 0.0%
SNYNF | News | $92.7 -2.18% 600K |

Health Technology

| 0.22% | O: 1.01% H: 0.0% C: -2.65%
NVSEF | $93.6375 6.88% 82K |

Health Technology

| 1.12% | O: 0.67% H: 0.0% C: 0.0%
NVS | $92.57 -0.55% 0.51% 0 |

Health Technology

| -1.04% | O: 0.91% H: 0.21% C: -0.01%
JNJ | News | $145.74 0.67% -0.18% 7M |

Health Technology

| -3.05% | O: 0.78% H: 0.0% C: 0.0%
GSK | $39.27 -0.83% 0.38% 3.8K |

Health Technology

| 14.98% | O: 1.05% H: 1.44% C: 1.15%
ABT | News | $105.27 -0.6% -0.38% 5.9M |

Health Technology

| 8.62% | O: 2.58% H: 0.0% C: 0.0%
SNY | News | $45.39 -1.56% -1.58% 4.3M |

Health Technology

| -1.19% | O: 1.42% H: 0.0% C: 0.0%
rare disease cell eye market

---

Digital Dose Inhaler Market Set for Remarkable Growth, Estimated at $104.3 Billion by 2033
Published: 2023-11-16 (Crawled : 01:00) - prnewswire.com
GLAXF | $20.2 0.65% -14.18% 0 |

Health Technology

| 18.48% | O: 0.59% H: 0.0% C: 0.0%
AZNCF | $138.24 -1.36% -4.19% 800 |

Health Technology

| 8.11% | O: -2.16% H: 4.44% C: 2.2%
GSK | $39.27 -0.83% 0.38% 3.8K |

Health Technology

| 14.88% | O: -0.15% H: 0.23% C: 0.06%
MMM | $91.48 0.57% -0.45% 2.4M |

Producer Manufacturing

| -6.05% | O: -0.96% H: 0.58% C: -0.19%
AZN | $68.36 -0.25% -0.25% 27K |

Health Technology

| 8.13% | O: 0.46% H: 0.71% C: 0.6%
set market

---

CureVac veröffentlicht Finanzergebnisse für das dritte Quartal sowie die ersten neun Monate 2023 und informiert über seine Geschäftsentwicklung
Published: 2023-11-14 (Crawled : 12:00) - curevac.com
GLAXF | $20.2 0.65% -14.18% 0 |

Health Technology

| 17.24% | O: 1.57% H: 0.0% C: 0.0%
GSK | $39.27 -0.83% 0.38% 3.8K |

Health Technology

| 14.42% | O: 0.12% H: 0.14% C: -0.49%
CVAC | News | $2.44 -5.06% -5.33% 120 |

Health Technology

| -55.72% | O: 3.45% H: 4.56% C: -0.7%

---

SCYNEXIS Reports Third Quarter 2023 Financial Results and Provides Corporate Update
Published: 2023-11-13 (Crawled : 22:00) - globenewswire.com
GSK | $39.27 -0.83% 0.38% 3.8K |

Health Technology

| 14.42% | O: 0.12% H: 0.14% C: -0.49%
SCYX | $1.405 -1.06% 3.4% 1.3K |

Health Technology

| -17.2% | O: 0.29% H: 4.94% C: -0.58%
update financial results

---

Adult Vitamin Gummies Market to grow by USD 2.75 billion from 2023-2028; North America to account for 41% of market growth - Technavio
Published: 2023-11-10 (Crawled : 23:00) - prnewswire.com
UNLYF | $47.95 2.02% 1.3% 0 |

Consumer Non-Durables

| Email alert Add to watchlist
UL | $46.85 0.34% 0.96% 540K |

Consumer Non-Durables

| Email alert Add to watchlist
GSK | $39.27 -0.83% 0.38% 3.8K |

Health Technology

| Email alert Add to watchlist
GLAXF | $20.2 0.65% -14.18% 0 |

Health Technology

| Email alert Add to watchlist
america growth market

---

23andMe Reports Second Quarter Fiscal 2024 Financial Results
Published: 2023-11-08 (Crawled : 21:00) - globenewswire.com
GSK | $39.27 -0.83% 0.38% 3.8K |

Health Technology

| 12.95% | O: 0.0% H: 0.03% C: -1.71%
financial results

---

Global mRNA Vaccine Market Research Report 2023-2028: COVID-19 Success Opens New Avenues with with 444 Ongoing Clinical Studies Worldwide
Published: 2023-11-08 (Crawled : 03:00) - prnewswire.com
GLAXF | $20.2 0.65% -14.18% 0 |

Health Technology

| 17.03% | O: 1.91% H: 0.0% C: 0.0%
VERV | $6.66 -1.19% -1.2% 1.2M |

Professional, Scientific, and T...

| -63.96% | O: 0.37% H: 0.64% C: -10.76%
GSK | $39.27 -0.83% 0.38% 3.8K |

Health Technology

| 13.21% | O: 0.46% H: 0.46% C: -0.23%
MRNA S | $102.0 -1.39% -1.4% 1.4M |

Health Technology

| 40.43% | O: -0.01% H: 0.03% C: -3.14%
CVAC | News | $2.44 -5.06% -5.33% 120 |

Health Technology

| -55.72% | O: 0.91% H: 1.08% C: -1.44%
BNTX | $86.17 -0.27% -0.24% 2.2K |

Health Technology

| -15.82% | O: 0.13% H: 0.08% C: -2.81%
ARCT 4 | $26.32 -4.78% -5.06% 0 |

Health Technology

| 34.35% | O: -0.36% H: 0.79% C: -0.61%
covid-19 success report vaccine mrna worldwide ongoing research global market

---

COVID-19 Challenges Drive the Need for Resilient Supply Chains and Digital Healthcare in the Anti-Epileptic Drugs Market, Shaping the Post-Pandemic Landscape
Published: 2023-11-06 (Crawled : 19:00) - prnewswire.com
GLAXF | $20.2 0.65% -14.18% 0 |

Health Technology

| 17.51% | O: 0.41% H: 0.0% C: 0.0%
VTRS | $11.12 0.18% 0.09% 130 |

Health Technology

| 20.74% | O: 0.11% H: 0.33% C: -0.98%
TEVA | $12.78 -3.03% -1.8% 8.4M |

Health Technology

| 45.64% | O: 0.22% H: 1.49% C: -0.33%
TAK | News | $13.16 0.08% 0.15% 2.1K |

Health Technology

| -4.08% | O: 0.44% H: 0.22% C: 0.07%
NVS | $92.57 -0.55% 0.51% 0 |

Health Technology

| -0.4% | O: 0.24% H: 0.18% C: 0.16%
JNJ | News | $145.74 0.67% -0.18% 7M |

Health Technology

| -4.43% | O: 0.18% H: 0.0% C: 0.0%
GSK | $39.27 -0.83% 0.38% 3.8K |

Health Technology

| 13.83% | O: 0.55% H: 0.3% C: 0.0%
ABT | News | $105.27 -0.6% -0.38% 5.9M |

Health Technology

| 11.32% | O: -0.42% H: 0.0% C: 0.0%
SNY | News | $45.39 -1.56% -1.58% 4.3M |

Health Technology

| -0.36% | O: -1.32% H: 0.0% C: 0.0%
covid-19

---

NeuroBo Pharmaceuticals Strengthens Board of Directors with the Appointment of James P. Tursi, M.D.
Published: 2023-11-06 (Crawled : 14:30) - biospace.com/
ENDPQ | $0.0006 -50.0% 3.4K |

n/a

| -20.0% | O: 40.0% H: 0.0% C: -25.71%
GLAXF | $20.2 0.65% -14.18% 0 |

Health Technology

| 19.17% | O: 1.89% H: 1.97% C: -0.46%
GSK | $39.27 -0.83% 0.38% 3.8K |

Health Technology

| 14.98% | O: 0.64% H: 0.82% C: 0.38%
NRBO | $3.44 -0.58% -1.02% 160 |

Health Technology

| 2.98% | O: 4.76% H: 0.0% C: -3.61%
pharmaceuticals

---

CureVac meldet Fortschritte in klinischen Phase-2-Entwicklungsprogrammen für COVID-19 und die saisonale Grippe in Zusammenarbeit mit GSK
Published: 2023-11-01 (Crawled : 13:00) - curevac.com
GLAXF | $20.2 0.65% -14.18% 0 |

Health Technology

| 12.22% | O: -1.62% H: 0.0% C: 0.0%
GSK | $39.27 -0.83% 0.38% 3.8K |

Health Technology

| 10.92% | O: -4.06% H: 1.9% C: 0.96%
CVAC | News | $2.44 -5.06% -5.33% 120 |

Health Technology

| -53.96% | O: 0.19% H: 3.95% C: -1.32%
covid-19 phase 2

---

Medical Segment Dominates, Expected to Reach $70.4 Billion by 2030 in the Global Recombinant DNA Technology Market
Published: 2023-11-01 (Crawled : 01:00) - prnewswire.com
GLAXF | $20.2 0.65% -14.18% 0 |

Health Technology

| 12.22% | O: -1.62% H: 0.0% C: 0.0%
SNYNF | News | $92.7 -2.18% 600K |

Health Technology

| 3.73% | O: 0.94% H: 2.55% C: 2.55%
NVSEF | $93.6375 6.88% 82K |

Health Technology

| 2.99% | O: 2.52% H: 0.04% C: 0.04%
NVO | $122.75 -1.43% 0.67% 42K |

Health Technology

| 28.95% | O: 0.87% H: 0.73% C: 0.28%
NVS | $92.57 -0.55% 0.51% 0 |

Health Technology

| -0.53% | O: 0.16% H: 0.7% C: 0.57%
GSK | $39.27 -0.83% 0.38% 3.8K |

Health Technology

| 10.92% | O: -4.06% H: 1.9% C: 0.96%
LLY | $745.95 -0.64% -0.13% 17K |

Health Technology

| 32.11% | O: -2.76% H: 0.0% C: 0.0%
SNY | News | $45.39 -1.56% -1.58% 4.3M |

Health Technology

| -0.11% | O: 0.18% H: 0.0% C: 0.0%
expected reach global dna medical technology market

---

Premature Ejaculation (PE) Treatment Market size to grow by USD 1.45 billion from 2023-2028| A. Menarini Industrie Farmaceutiche Riunite Srl, Absorption Pharmaceuticals LLC, Alembic Pharmaceuticals Ltd., and more among the key companies in the market - Technavio
Published: 2023-10-31 (Crawled : 22:00) - prnewswire.com
GLAXF | $20.2 0.65% -14.18% 0 |

Health Technology

| 12.22% | O: -1.62% H: 0.0% C: 0.0%
GSK | $39.27 -0.83% 0.38% 3.8K |

Health Technology

| 10.92% | O: -4.06% H: 1.9% C: 0.96%
VERU | $1.42 22.41% 12.12% 68K |

Health Technology

| 57.27% | O: 2.9% H: 2.25% C: -6.4%
companies treatment pharmaceuticals market

---

CureVac veröffentlicht am 14. November 2023 Finanzergebnisse des dritten Quartals sowie der ersten neun Monate 2023 und informiert über seine Geschäftsentwicklung
Published: 2023-10-31 (Crawled : 15:30) - curevac.com
GSK | $39.27 -0.83% 0.38% 3.8K |

Health Technology

| 12.28% | O: 0.34% H: 0.9% C: 0.88%
CVAC | News | $2.44 -5.06% -5.33% 120 |

Health Technology

| -52.44% | O: -0.58% H: 6.08% C: 3.92%

---

23andMe Announces Collaboration Extension with a New Data Licensing Agreement with GSK
Published: 2023-10-30 (Crawled : 12:00) - globenewswire.com
GSK | $39.27 -0.83% 0.38% 3.8K |

Health Technology

| 14.58% | O: 2.29% H: 0.44% C: -0.23%
collaboration extension agreement

---

Anti-inflammatory Therapeutics Market Size to Hit US$ 149.5 billion by 2031 | Exclusive Study by Transparency Market Research
Published: 2023-10-30 (Crawled : 09:00) - prnewswire.com
GLAXF | $20.2 0.65% -14.18% 0 |

Health Technology

| 12.22% | O: -4.67% H: 4.9% C: 4.9%
SNYNF | News | $92.7 -2.18% 600K |

Health Technology

| 7.64% | O: 2.76% H: 0.0% C: 0.0%
PFE A | $25.39 -0.12% -0.08% 190K |

Health Technology

| -15.58% | O: 0.43% H: 1.46% C: 1.03%
NVS | $92.57 -0.55% 0.51% 0 |

Health Technology

| 0.88% | O: 1.69% H: 0.25% C: -0.07%
JNJ | News | $145.74 0.67% -0.18% 7M |

Health Technology

| -2.16% | O: -1.39% H: 0.79% C: 0.64%
GSK | $39.27 -0.83% 0.38% 3.8K |

Health Technology

| 14.58% | O: 2.29% H: 0.44% C: -0.23%
ABBV | News | $164.66 0.25% -0.55% 0 |

Health Technology

| 20.02% | O: 2.87% H: 0.0% C: 0.0%
SNY | News | $45.39 -1.56% -1.58% 4.3M |

Health Technology

| 1.63% | O: -0.85% H: 0.0% C: 0.0%
research therapeutics study market

---

Non-alcoholic Steatohepatitis Market to grow by USD 11.22 billion from 2022 to 2027, North America to account for 51% of market growth- Technavio
Published: 2023-10-27 (Crawled : 19:00) - prnewswire.com
AZN | $68.36 -0.25% -0.25% 27K |

Health Technology

| Email alert Add to watchlist
AZNCF | $138.24 -1.36% -4.19% 800 |

Health Technology

| Email alert Add to watchlist
GLAXF | $20.2 0.65% -14.18% 0 |

Health Technology

| Email alert Add to watchlist
IVEVF | $3.73 0% 1K |

n/a

| Email alert Add to watchlist
IVA | $3.45 7.14% 1.83% 12K |

Health Technology

| Email alert Add to watchlist
GSK | $39.27 -0.83% 0.38% 3.8K |

Health Technology

| Email alert Add to watchlist
america market

---

Gainers vs Losers

58%

42%

Top 10 Gainers

ZCMD | $1.45 5.84% 49.63% 15M |

Commercial Services

AULT | $0.2421 -7.7% 45.23% 16M |

Manufacturing

XPON | News | $3.15 63.21% 33.9% 100K |

EGOX | $0.036 12.15% 31.56% 32M |

TIRX | $0.8 65.02% 25.95% 410K |

VTNR 4 | $1.31 33.78% 25.82% 220K |

Industrial Services

GDHG | $0.263 21.76% 25.34% 1.3M |

TPET | $0.3279 -3.56% 23.57% 11M |

n/a

HOLO | $2.95 31.7% 22.49% 37M |

MTNB | $0.19 -1.04% 14.58% 950K |

Health Technology

---

Your saved searches

---